{"AAP": {"Ticker": "AAP", "Company": "Advance Auto Parts", "Sector": "Consumer Discretionary", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2023-02-13", "Rating": "Downgrade", "Organization": "ROTH MKM", "Rating_Change": "Buy to Neutral", "Target_Change": "$180 to $140"}, {"Date": "2023-02-08", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Underweight", "Target_Change": "$145"}, {"Date": "2023-01-12", "Rating": "Downgrade", "Organization": "Wedbush", "Rating_Change": "Outperform to Neutral", "Target_Change": "$145"}], "Score": -1.25, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Argus", "Barclays", "Wedbush", "ROTH MKM"], "Price_Target": 143.33}, "APD": {"Ticker": "APD", "Company": "Air Products & Chemicals", "Sector": "Materials", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Upgrade", "Organization": "Vertical Research", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2023-01-10", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$335"}, {"Date": "2023-01-04", "Rating": "Downgrade", "Organization": "Vertical Research", "Rating_Change": "Buy to Hold", "Target_Change": "$328"}], "Score": -0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Vertical Research", "Morgan Stanley"], "Price_Target": 331.5}, "AMGN": {"Ticker": "AMGN", "Company": "Amgen", "Sector": "Health Care", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$275 to $265"}, {"Date": "2023-02-13", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$280 to $260"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Truist", "Wells Fargo"], "Price_Target": 262.5}, "SCHW": {"Ticker": "SCHW", "Company": "Charles Schwab Corporation", "Sector": "Financials", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$83 to $75"}, {"Date": "2023-01-19", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Underperform", "Target_Change": "$92 to $75"}, {"Date": "2023-01-04", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$98"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["BofA Securities", "Citigroup", "Goldman"], "Price_Target": 82.67}, "CMA": {"Ticker": "CMA", "Company": "Comerica", "Sector": "Financials", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Odeon", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2023-02-15", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$77 to $82"}, {"Date": "2023-01-10", "Rating": "Upgrade", "Organization": "Odeon", "Rating_Change": "Hold to Buy", "Target_Change": "$76.36"}, {"Date": "2022-12-21", "Rating": "Upgrade", "Organization": "DA Davidson", "Rating_Change": "Neutral to Buy", "Target_Change": "$78 to $80"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["DA Davidson", "Odeon", "Piper Sandler"], "Price_Target": 81.0}, "LLY": {"Ticker": "LLY", "Company": "Eli Lilly & Co", "Sector": "Health Care", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$360 to $375"}, {"Date": "2023-03-06", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$290"}, {"Date": "2023-02-15", "Rating": "Downgrade", "Organization": "Societe Generale", "Rating_Change": "Hold to Sell", "Target_Change": ""}], "Score": -0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Societe Generale", "Wells Fargo"], "Price_Target": 332.5}, "FRC": {"Ticker": "FRC", "Company": "First Republic Bank", "Sector": "Financials", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Strong Buy to Mkt Perform", "Target_Change": ""}, {"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Compass Point", "Rating_Change": "Buy to Neutral", "Target_Change": "$168 to $130"}, {"Date": "2023-01-09", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2023-01-05", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$142"}, {"Date": "2022-12-15", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$100 to $125"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Wells Fargo", "Compass Point", "Raymond James", "Wolfe Research", "Goldman"], "Price_Target": 132.33}, "JPM": {"Ticker": "JPM", "Company": "JPMorgan Chase", "Sector": "Financials", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$148 to $155"}, {"Date": "2023-01-06", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$145"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Deutsche Bank", "Wells Fargo"], "Price_Target": 150.0}, "KEY": {"Ticker": "KEY", "Company": "KeyCorp", "Sector": "Financials", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Odeon", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2023-03-10", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$20"}, {"Date": "2023-03-10", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Underweight to Neutral", "Target_Change": "$18.50 to $16.50"}, {"Date": "2023-01-10", "Rating": "Upgrade", "Organization": "Odeon", "Rating_Change": "Hold to Buy", "Target_Change": "$20.36"}, {"Date": "2023-01-03", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$21 to $24"}, {"Date": "2022-12-21", "Rating": "Initiated", "Organization": "DA Davidson", "Rating_Change": "Buy", "Target_Change": "$20"}], "Score": 1.17, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Robert W. Baird", "Odeon", "Piper Sandler", "DA Davidson", "Barclays"], "Price_Target": 21.33}, "LRCX": {"Ticker": "LRCX", "Company": "Lam Research", "Sector": "Information Technology", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Bernstein", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2023-01-18", "Rating": "Resumed", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$495"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Stifel", "Bernstein"], "Price_Target": 495.0}, "MRK": {"Ticker": "MRK", "Company": "Merck & Co.", "Sector": "Health Care", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$120 to $115"}, {"Date": "2023-03-06", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$125"}, {"Date": "2023-02-22", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": "$127"}, {"Date": "2023-01-04", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$110 to $130"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["BofA Securities", "Wolfe Research", "Jefferies", "Wells Fargo"], "Price_Target": 124.25}, "MRNA": {"Ticker": "MRNA", "Company": "Moderna", "Sector": "Health Care", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Upgrade", "Organization": "TD Cowen", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$150 to $180"}, {"Date": "2023-03-02", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$200"}, {"Date": "2023-02-24", "Rating": "Downgrade", "Organization": "SVB Securities", "Rating_Change": "Market Perform to Underperform", "Target_Change": "$111 to $93"}, {"Date": "2022-12-19", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$170 to $275"}, {"Date": "2022-12-14", "Rating": "Downgrade", "Organization": "Chardan Capital Markets", "Rating_Change": "Buy to Neutral", "Target_Change": "$186 to $191"}], "Score": 0.6, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "B", "Analists": ["RBC Capital Mkts", "Jefferies", "SVB Securities", "Chardan Capital Markets", "TD Cowen"], "Price_Target": 187.8}, "PNC": {"Ticker": "PNC", "Company": "PNC Financial Services", "Sector": "Financials", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$175"}, {"Date": "2023-01-10", "Rating": "Upgrade", "Organization": "Odeon", "Rating_Change": "Hold to Buy", "Target_Change": "$176.27"}, {"Date": "2023-01-10", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$190 to $176"}, {"Date": "2023-01-06", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$200 to $190"}, {"Date": "2023-01-05", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$157 to $160"}], "Score": 0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["BofA Securities", "Odeon", "UBS", "Citigroup", "Deutsche Bank"], "Price_Target": 175.25}, "TSLA": {"Ticker": "TSLA", "Company": "Tesla", "Sector": "Consumer Discretionary", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2023-03-08", "Rating": "Downgrade", "Organization": "Berenberg", "Rating_Change": "Buy to Hold", "Target_Change": "$200 to $210"}, {"Date": "2023-02-15", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$275"}, {"Date": "2023-01-30", "Rating": "Upgrade", "Organization": "Berenberg", "Rating_Change": "Hold to Buy", "Target_Change": "$255 to $200"}, {"Date": "2023-01-27", "Rating": "Reiterated", "Organization": "Argus", "Rating_Change": "Buy", "Target_Change": "$374 to $257"}, {"Date": "2023-01-23", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$299 to $245"}, {"Date": "2023-01-13", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Sell", "Target_Change": ""}, {"Date": "2023-01-09", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$275 to $135"}, {"Date": "2023-01-05", "Rating": "Upgrade", "Organization": "Edward Jones", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2023-01-03", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$348 to $299"}, {"Date": "2023-01-03", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Underweight", "Target_Change": "$150 to $125"}, {"Date": "2023-01-03", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$235 to $205"}, {"Date": "2022-12-29", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$330 to $250"}, {"Date": "2022-12-28", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$316 to $252"}, {"Date": "2022-12-23", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Outperform", "Target_Change": "$250 to $175"}, {"Date": "2022-12-22", "Rating": "Reiterated", "Organization": "Canaccord Genuity", "Rating_Change": "Buy", "Target_Change": "$304 to $275"}, {"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}], "Score": 0.82, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 17, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Berenberg", "BofA Securities", "Argus", "Robert W. Baird", "Canaccord Genuity", "Wedbush", "Truist", "Guggenheim", "Morgan Stanley", "Oppenheimer", "Barclays", "JP Morgan", "Edward Jones", "Wolfe Research", "Goldman"], "Price_Target": 223.31}, "TFC": {"Ticker": "TFC", "Company": "Truist Financial", "Sector": "Financials", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$53"}, {"Date": "2023-03-13", "Rating": "Upgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Underperform to Mkt Perform", "Target_Change": "$47 to $45"}, {"Date": "2023-01-31", "Rating": "Downgrade", "Organization": "Stephens", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$53"}, {"Date": "2023-01-09", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$48"}, {"Date": "2023-01-06", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$61 to $48"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Stephens", "Robert W. Baird", "Keefe Bruyette", "Deutsche Bank"], "Price_Target": 49.4}, "UAA": {"Ticker": "UAA", "Company": "Under Armour (Class A)", "Sector": "Consumer Discretionary", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$13 to $10"}, {"Date": "2023-01-17", "Rating": "Upgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Neutral to Outperform", "Target_Change": ""}, {"Date": "2022-12-22", "Rating": "Reiterated", "Organization": "Telsey Advisory Group", "Rating_Change": "Market Perform", "Target_Change": "$9 to $11"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Telsey Advisory Group", "Exane BNP Paribas", "JP Morgan"], "Price_Target": 10.5}, "WFC": {"Ticker": "WFC", "Company": "Wells Fargo", "Sector": "Financials", "Updated": "2023-03-13", "Rating": [{"Date": "2023-03-13", "Rating": "Downgrade", "Organization": "Odeon", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2023-01-17", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$49 to $47"}, {"Date": "2023-01-17", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$49 to $46"}, {"Date": "2023-01-10", "Rating": "Upgrade", "Organization": "Odeon", "Rating_Change": "Hold to Buy", "Target_Change": "$51.79"}], "Score": -0.75, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Odeon", "Piper Sandler", "Jefferies"], "Price_Target": 46.5}}